Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations.

ESMO open(2022)

引用 3|浏览5
暂无评分
摘要
Overall, our hypothesis-generating findings may help to stratify patients in clinical trials and guide optimal targeted therapy in those with FGFR alterations.
更多
查看译文
关键词
FGFR inhibitors,FGFR1-4,gene rearrangements/fusions,short variants,targeted therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要